Tata India Pharma & HealthCare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Tata India Pharma & HealthCare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

₹1,511 Cr

Lock In Period

N/A

Expense Ratio

2.37

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

Benchmark

BSE Healthcare Total Return

Tata India Pharma & HealthCare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-1.51-0.291.18
6M6.171.6719.13
1Y2.823.0323.31
3Y17.5513.51122.39

Portfolio Analysis

  • Equity: 99.72%
  • Debt: 0.28%
  • Others
As on: 2026-09-30
View allocation % by

1. SUN PHARMACEUTICAL INDUSTRIES LTD7.99%
2. ABBOTT INDIA LTD5.94%
3. DIVI LABORATORIES LTD5.68%
4. DR REDDYS LABORATORIES LTD4.65%
5. CIPLA LTD4.22%
6. TORRENT PHARMACEUTICALS LTD3.76%
7. LUPIN LTD3.14%
8. SYNGENE INTERNATIONAL LTD2.85%
9. PROCTER & GAMBLE HEALTH LTD2.75%
10. SAI LIFE SCIENCES LTD2.60%
11. ANTHEM BIOSCIENCES LTD2.57%
12. PFIZER LTD2.50%
13. ALKEM LABORATORIES LTD2.36%
14. FDC LTD2.24%
15. ACUTAAS CHEMICALS LTD1.95%
16. AJANTA PHARMA LTD1.63%
17. NATCO PHARMA LTD1.51%
18. IPCA LABORATORIES LTD0.91%
19. SYMBIOTEC PHARMALAB LTD0.87%
20. MANKIND PHARMA LTD0.77%
21. GLAXOSMITHKLINE PHARMACEUTICALS LTD0.76%
22. BIOCON LTD0.69%
23. ZIM LABORATORIES LTD0.58%
24. JUBILANT PHARMOVA LTD0.00%

1. HEALTHCARE GLOBAL ENTERPRISES LTD5.92%
2. APOLLO HOSPITALS ENTERPRISE LTD4.36%
3. RAINBOW CHILDRENS MEDICARE LTD4.30%
4. MAX HEALTHCARE INSTITUTE LTD3.71%
5. FORTIS HEALTHCARE LTD1.95%
6. DR. LAL PATH LABS LTD1.76%
7. ASTER DM QUALITY CARE LTD1.67%
8. DR. AGARWALS HEALTH CARE LTD0.68%
9. MANIPAL HEALTH ENTERPRISES LTD0.59%
10. MOLBIO DIAGNOSTICS LTD0.54%

1. BAYER CROPSCIENCE LTD2.96%
2. PI INDUSTRIES LTD2.59%
3. SUMITOMO CHEMICAL INDIA LTD1.38%

1. GILLETTE INDIA LTD1.23%

1. NAVIN FLUORINE INTERNATIONAL LTD1.18%

1. SANOFI CONSUMER HEALTHCARE INDIA LTD0.57%
2. GUJARAT FLUOROCHEMICALS LTD0.53%
No Data Found
No Data Found

About Fund Tata India Pharma & HealthCare Fund Growth

Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,511 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.37. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Rajat Srivastava

Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.

Tata India Pharma & HealthCare Fund Growth FAQs

Tata India Pharma & HealthCare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Tata India Pharma & HealthCare Fund Growth is 2.37. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Tata India Pharma & HealthCare Fund Growth’s fund performance is as follows:
  • 1 Month : -1.51%
  • 6 Months : 6.17%
  • 1 Year : 2.82%
  • 3 Years : 17.55%
Returns of Tata India Pharma & HealthCare Fund Growth are updated daily based on NAV of ₹ 31.8801 as on Oct 30,2026. Since inception, the return has been 62.42%.

You can invest in Tata India Pharma & HealthCare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Tata India Pharma & HealthCare Fund Growth is ₹1,511 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Tata India Pharma & HealthCare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC